-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$31.4460.74% Upside
Recent Analyst Forecasts and Stock Ratings
The Chemours Company Frequently Asked Questions
-
What analysts cover The Chemours Company?
The Chemours Company has been rated by research analysts at BMO Capital, Mizuho Securities, UBS, CFRA, D.A. Davidson, RBC Capital in the past 90 days.